MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$176,708,000
Net loss
-$170,370,000
Other comprehensive
income (loss)
-$6,338,000
Provision (benefit) for
income taxes
-$88,000
Other income, net
$9,289,000
PAHResearch And Development
Services Expenses...
$15,999,000
PHILDResearch And Development
Services Expenses...
$13,578,000
PAHResearch And Development
Services Performance...
$9,436,000
PAHCommercial Expenses
Subject To...
$5,554,000
PHILDResearch And Development
Services Performance...
$3,311,000
PHILDCommercial Expenses
Subject To...
$665,000
Interest income
$1,970,000
Loss before
provision (benefit) for...
-$170,458,000
Foreign currency
translation
-$6,248,000
Unrealized income (loss) on
marketable securities
-$90,000
Total other income,
net
$270,000
Revenue From Contracts
With Collaborators
$48,471,000
Interest expense
$10,989,000
Effects Of Exchange Rate
-$72,000
Loss from operations
-$170,728,000
Total revenue
$48,471,000
Total operating
expenses
$219,199,000
Research and development
$174,093,000
General and
administrative
$37,631,000
In process
research and development
$7,475,000
Back
Back
Income Statement
source: myfinsight.com
Gossamer Bio, Inc. (GOSS)
Gossamer Bio, Inc. (GOSS)